Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Francophone Des Myélodysplasies
(1)
,
(2)
,
(3)
,
(4)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
,
(10)
,
(11)
,
(12)
,
,
(13)
,
(14)
,
(14)
,
(1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
2
3
4
5
6
7
8
9
10
11
12
13
14
Lionel Adès
- Function : Author
- PersonId : 762488
- ORCID : 0000-0002-9020-8766
Christian Recher
- Function : Author
- PersonId : 758643
- ORCID : 0000-0002-3332-4525
Mathilde Hunault
- Function : Author
- PersonId : 752203
- IdHAL : mathilde-hunault-berger
- ORCID : 0000-0001-7777-5216
Eric Wattel
- Function : Author
- PersonId : 837570
Laure Stalnikiewicz
- Function : Author
Norbert Vey
- Function : Author
- PersonId : 762211
- ORCID : 0000-0001-7027-040X
Marie Sebert
- Function : Author